Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Flotufolastat F 18 Positron Emission Tomography in Men With Very Low Prostate Specific Antigen Recurrence

NCT06862856 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06862856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06862856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Flotufolastat F 18 Positron Emission Tomography in Men With Very Low Prostate Specific Antigen Recurrence
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Recruiting
Start date
May 20, 2025
Completion date
December 1, 2026
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer (adenocarcinoma), prostate specific antigen